Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myeloproliferative Disorders × lenvatinib × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Neoplasms 8 Carcinoma, Hepatocellular 8 Thyroid Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Cancer, Papillary 3 Colorectal Neoplasms 3 Adenocarcinoma, Follicular 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoma 2 Glioma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, medullary 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1

Interventions

fludarabine phosphate 36 Whole-Body Irradiation 29 Mycophenolic Acid 27 Cyclophosphamide 26 Peripheral Blood Stem Cell Transplantation 24 Tacrolimus 21 Busulfan 18 Antilymphocyte Serum 18 fludarabine 16 Cyclosporine 14 ruxolitinib 13 Melphalan 13 Cytarabine 11 Methotrexate 10 thymoglobulin 9 Etoposide 9 Sirolimus 8 Filgrastim 7 Cyclosporins 7 Rituximab 6 Granulocyte Colony-Stimulating Factor 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Alemtuzumab 5 ponatinib 4 Flow Cytometry 4 Azacitidine 4 Stem Cell Transplantation 3 Methylprednisolone 3 Mesna 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡